The happy saga of Australian tech entrepreneur Paul Conyngham and his dog Rosie is all over the internet. Conyngham's 8-year-old rescue dog, Rosie, was diagnosed with a fatal skin cancer. Instead of accepting Rosie's allegedly inevitable demise, Conyngham turned to artificial intelligence (both ChatGPT and Grok) to see if he could figure out how to create a personalized anti-cancer vaccine.
Conyngham reached out to Martin Smith, the director of the University of New South Wales (UNSW) Ramaciotti Centre for Genomics, to genetically sequence the DNA from both Rosie and her tumor. They agreed, and Conyngham paid $3,000 for the sequences. (It's worth noting that San Diego–based Element Biosciences soon plans to offer whole genome sequencing for $100.) Then he used Google's DeepMind AlphaFold and ChatGPT to analyze the genetic information and to identify mutated proteins produced by the tumors.
